-
1
-
-
0032757723
-
Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans
-
Brown P, Cervanakova L, McShane LM, Barber P, Rubenstein R, Drohan WN. Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans. Transfusion 1999;39:1169-78.
-
(1999)
Transfusion
, vol.39
, pp. 1169-1178
-
-
Brown, P.1
Cervanakova, L.2
McShane, L.M.3
Barber, P.4
Rubenstein, R.5
Drohan, W.N.6
-
2
-
-
0342951746
-
A new variant of Creutzfeldt-Jakob disease in the UK
-
Will R, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996;347:921-5.
-
(1996)
Lancet
, vol.347
, pp. 921-925
-
-
Will, R.1
Ironside, J.W.2
Zeidler, M.3
-
3
-
-
0035820405
-
Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease
-
Brown P. Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease. BMJ 2001;322:841-4.
-
(2001)
BMJ
, vol.322
, pp. 841-844
-
-
Brown, P.1
-
4
-
-
0032612107
-
BSE: Transmission studies with particular reference to blood
-
Brown F, Cartwright T, Horaud F, Speiser JM, editors. Animal sera, animal sera derivatives and substitutes used in the manufacture of pharmaceuticals: viral safety and regulatory aspects
-
Bradley R. BSE: transmission studies with particular reference to blood. In: Brown F, Cartwright T, Horaud F, Speiser JM, editors. Animal sera, animal sera derivatives and substitutes used in the manufacture of pharmaceuticals: viral safety and regulatory aspects. Dev Biol (Basel) 1999;99:35-40.
-
(1999)
Dev Biol (Basel)
, vol.99
, pp. 35-40
-
-
Bradley, R.1
-
5
-
-
0036843096
-
Transmission of prion diseases by blood transfusion
-
Hunter N, Foster J, Chong A, McCutcheon S, Parnham D, Eaton S, et al. Transmission of prion diseases by blood transfusion. J Gen Vir 2002;83:2897-905.
-
(2002)
J Gen Vir
, vol.83
, pp. 2897-2905
-
-
Hunter, N.1
Foster, J.2
Chong, A.3
McCutcheon, S.4
Parnham, D.5
Eaton, S.6
-
6
-
-
0020522298
-
Creutzfeldt-Jakob disease in mice: Persistent viremia and preferential replication of virus in low-density lymphocytes
-
Kuroda Y, Gibbs CJ Jr, Amyx HL, Gajdusek DC. Creutzfeldt-Jakob disease in mice: persistent viremia and preferential replication of virus in low-density lymphocytes. Infect Immun 1983;41:154-61.
-
(1983)
Infect Immun
, vol.41
, pp. 154-161
-
-
Kuroda, Y.1
Gibbs C.J., Jr.2
Amyx, H.L.3
Gajdusek, D.C.4
-
7
-
-
0003242754
-
Titre, distribution, and transmissibility of blood-borne TSE infectivity
-
MacLean, Virginia, February 13-15
-
Rohwer RG. Titre. distribution, and transmissibility of blood-borne TSE infectivity. Presented at the 6th Annual Meeting of the Cambridge Healthtech Institute, "Blood product safety: TSE, perception versus reality." MacLean, Virginia, February 13-15, 2000.
-
(2000)
6th Annual Meeting of the Cambridge Healthtech Institute, "Blood Product Safety: TSE, Perception Versus Reality"
-
-
Rohwer, R.G.1
-
8
-
-
3543092761
-
The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy
-
Brown P, Rohwer RG, Dunstan BS, MacAuley C, Gajdusek DC, Drohan WN. The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy. Transfusion 1998;38:810-6.
-
(1998)
Transfusion
, vol.38
, pp. 810-816
-
-
Brown, P.1
Rohwer, R.G.2
Dunstan, B.S.3
MacAuley, C.4
Gajdusek, D.C.5
Drohan, W.N.6
-
9
-
-
0033847725
-
Different levels of prion protein (PrPc) expression on hamster, mouse and human blood cells
-
Holada K, Vostal JG. Different levels of prion protein (PrPc) expression on hamster, mouse and human blood cells. Br J Haematol 2000;110:472-80.
-
(2000)
Br J Haematol
, vol.110
, pp. 472-480
-
-
Holada, K.1
Vostal, J.G.2
-
10
-
-
0035108652
-
The pathogenesis of transmissible spongiform encephalopathy: Routes to the brain and the erection of therapeutic barricades
-
Brown P. The pathogenesis of transmissible spongiform encephalopathy: routes to the brain and the erection of therapeutic barricades. Cell Mol Life Sci 2001;58:259-65.
-
(2001)
Cell Mol Life Sci
, vol.58
, pp. 259-265
-
-
Brown, P.1
-
11
-
-
0027447219
-
Transmission of Creutzfeldt-Jakob disease by blood transfusion
-
Klein R, Duble LJ. Transmission of Creutzfeldt-Jakob disease by blood transfusion. Lancet 1993;341:205-7.
-
(1993)
Lancet
, vol.341
, pp. 205-207
-
-
Klein, R.1
Duble, L.J.2
-
12
-
-
0029125679
-
Creutzfeldt-Jakob disease after liver transplantation
-
Créange A, Gray F, Cesaro P, et al. Creutzfeldt-Jakob disease after liver transplantation. Ann Neurol 1995;38:269-72.
-
(1995)
Ann Neurol
, vol.38
, pp. 269-272
-
-
Créange, A.1
Gray, F.2
Cesaro, P.3
-
13
-
-
0031747570
-
Creutzfeldt-Jakob disease (CJD) after blood product transfusion from a donor with CJD
-
Patry D, Curry B, Easton D, et al. Creutzfeldt-Jakob disease (CJD) after blood product transfusion from a donor with CJD. Neurology 1998;50:1872-3.
-
(1998)
Neurology
, vol.50
, pp. 1872-1873
-
-
Patry, D.1
Curry, B.2
Easton, D.3
-
15
-
-
0034237683
-
Risk of acquiring Creutzfeldt-Jakob disease from blood transfusions: Systematic review of case-control studies
-
Wilson K, Code C, Ricketts MN. Risk of acquiring Creutzfeldt-Jakob disease from blood transfusions: systematic review of case-control studies. BMJ 2000;321:17-9.
-
(2000)
BMJ
, vol.321
, pp. 17-19
-
-
Wilson, K.1
Code, C.2
Ricketts, M.N.3
-
16
-
-
0031682547
-
Surveillance for Creutzfeldt-Jakob disease among persons with haemophilia
-
Evatt B, Austin E, Barnhart L, et al. Surveillance for Creutzfeldt-Jakob disease among persons with haemophilia. Transfusion 1998;38:817-20.
-
(1998)
Transfusion
, vol.38
, pp. 817-820
-
-
Evatt, B.1
Austin, E.2
Barnhart, L.3
-
17
-
-
0031766582
-
Retrospective neuropathological review of prion disease in UK haemophiliac patients
-
Lee CA, Ironside JW, Bell JE, et al. Retrospective neuropathological review of prion disease in UK haemophiliac patients. Thromb Haemost 1998;80:909-11.
-
(1998)
Thromb Haemost
, vol.80
, pp. 909-911
-
-
Lee, C.A.1
Ironside, J.W.2
Bell, J.E.3
-
18
-
-
0028128111
-
Creutzfeldt-Jakob disease and blood transfusion
-
Heye N, Hensen S, Muller N. Creutzfeldt-Jakob disease and blood transfusion. Lancet 1994;343:298-9.
-
(1994)
Lancet
, vol.343
, pp. 298-299
-
-
Heye, N.1
Hensen, S.2
Muller, N.3
-
19
-
-
0028879731
-
Pooled plasma derivatives and Creutzfeldt-Jakob disease
-
Operskalski EA, Mosley JW. Pooled plasma derivatives and Creutzfeldt-Jakob disease. Lancet 1995;346:1224.
-
(1995)
Lancet
, vol.346
, pp. 1224
-
-
Operskalski, E.A.1
Mosley, J.W.2
-
21
-
-
0033855746
-
European surveillance on Creutzfeldt-Jakob disease: A case-control study for medical risk factors
-
Zerr I, Brandel J-P, Masullo C, et al. European surveillance on Creutzfeldt-Jakob disease: a case-control study for medical risk factors. J Clin Epidemiol 2000;53:747-54.
-
(2000)
J Clin Epidemiol
, vol.53
, pp. 747-754
-
-
Zerr, I.1
Brandel, J.-P.2
Masullo, C.3
-
22
-
-
0030255674
-
Creutzfeldt-Jakob disease in the United States, 1979-1994: Using national mortality data to assess the possible occurrence of variant cases
-
Holman RC, Khan AS, Belay ED, Schonberger LB. Creutzfeldt-Jakob disease in the United States, 1979-1994: using national mortality data to assess the possible occurrence of variant cases. Emerg Infect Dis 1996;2:333-7.
-
(1996)
Emerg Infect Dis
, vol.2
, pp. 333-337
-
-
Holman, R.C.1
Khan, A.S.2
Belay, E.D.3
Schonberger, L.B.4
-
23
-
-
0031735778
-
Creutzfeldt-Jakob disease and the risk from blood or blood products
-
Will RG, Kimberlin RH. Creutzfeldt-Jakob disease and the risk from blood or blood products. Vox Sang 1998;75:178-80.
-
(1998)
Vox Sang
, vol.75
, pp. 178-180
-
-
Will, R.G.1
Kimberlin, R.H.2
-
24
-
-
85031181999
-
Report on the safety of ruminant blood with respect to TSE risks
-
Paper presented, Brussels, Germany, April 13-14
-
Budka H, Pocchiari M, Aguzzi A, et al. Report on the safety of ruminant blood with respect to TSE risks, Paper presented at the meeting of the Scientific Steering Committee, Brussels, Germany, April 13-14, 2000.
-
(2000)
Meeting of the Scientific Steering Committee
-
-
Budka, H.1
Pocchiari, M.2
Aguzzi, A.3
-
25
-
-
0032578283
-
Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease
-
Hilton DA, Fathers E, Edwards P, Ironside JW, Zajicek J. Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet 1998;352:703-4.
-
(1998)
Lancet
, vol.352
, pp. 703-704
-
-
Hilton, D.A.1
Fathers, E.2
Edwards, P.3
Ironside, J.W.4
Zajicek, J.5
-
26
-
-
0033573778
-
Investigation of variant Creutzfeldt-Jakob and other human prion diseases with tonsil biopsy samples
-
Hill AF, Butterworth RJ, Jointer S, et al. Investigation of variant Creutzfeldt-Jakob and other human prion diseases with tonsil biopsy samples. Lancet 1999;353:183-99.
-
(1999)
Lancet
, vol.353
, pp. 183-199
-
-
Hill, A.F.1
Butterworth, R.J.2
Jointer, S.3
-
27
-
-
0035957401
-
Adaptation of the BSE agent to primates and comparison with Creutzfeldt-Jakob disease: Implications for human health
-
Lazmézas CI, Fournier J-G, Nouvel V, et al. Adaptation of the BSE agent to primates and comparison with Creutzfeldt-Jakob disease: implications for human health. Proc Natl Acad Sci USA 2001;98:4142-7.
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 4142-4147
-
-
Lazmézas, C.I.1
Fournier, J.-G.2
Nouvel, V.3
-
28
-
-
1642521478
-
Delay in plasma replacement
-
Warden J. Delay in plasma replacement. BMJ 1998;317:1409.
-
(1998)
BMJ
, vol.317
, pp. 1409
-
-
Warden, J.1
-
29
-
-
0030771006
-
Potential increased risk of virus transmission due to exclusion of older donors because of concern over Creutzfeldt-Jakob disease. The National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study
-
Busch MP, Glynn SA, Schreiber GB. Potential increased risk of virus transmission due to exclusion of older donors because of concern over Creutzfeldt-Jakob disease. The National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study. Transfusion 1997; 37:996-1002.
-
(1997)
Transfusion
, vol.37
, pp. 996-1002
-
-
Busch, M.P.1
Glynn, S.A.2
Schreiber, G.B.3
-
30
-
-
0034711323
-
Variant Creutzfeldt-Jakob disease (vCJD): Precautionary measures against the risk of transmission of the agent of vCJD by blood transfusion
-
World Health Organization. Variant Creutzfeldt-Jakob disease (vCJD): precautionary measures against the risk of transmission of the agent of vCJD by blood transfusion. Weekly Epidemiologic Record No. 47, 2000;75:377-8.
-
(2000)
Weekly Epidemiologic Record No. 47
, vol.75
, pp. 377-378
-
-
|